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Results All but one screening was successful, and no
wound infections at the electrode or at the pocket of the
stimulator were noted (mean postoperative follow-up, 8
weeks). Conclusions With the use of a video optic, the
anus and the implantation site can be completely separated
and contamination during the operation becomes unlikely.
Furthermore, the response of the pelvic floor to the stimu-
lation is better visualized. We routinely recommend the use
of video equipment for SNS electrode implantation.
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Introduction
Since the first description of sacral nerve stimulation
(SNS) by Pescatori et al. in 1982 [1] and then by Tanagho
et al. [2] in 1989, SNS is becoming an accepted therapy for
patients with urinary or bowel dysfunction [3–7]. In the
last few years the operative technique has changed: the
procedure has become minimally invasive [6] and the
complex three-stage intervention was successfully altered
to a two-stage implantation [8, 9]. All these improvements
have increased the success rate and have allowed clini-
cians to perform the procedure under local anaesthesia and
in an outpatient setting [10].
The procedure’s Achilles’ heel, however, is the high
infection rate. Infection can occur early during the screen-
ing phase or later after permanent implantation of the stim-
ulator. Infected screening leads require removal and inter-
ruption of the testing phase; this occurs in up to 20% of
patients [11]. Wound infection after implantation of the
neurostimulator is treated similarly, however the loss of
the stimulator dramatically increases costs. In our experi-
ence of 36 permanent implantations over a four-year peri-
F.H. Hetzer • D. Hahnloser • P.A. Clavien • N. Demartines
Video-assisted sacral nerve stimulation
Received: 20 September 2005 / Accepted: 3 October 2005 / Published online: 19 June 2006
O R I G I N A L A R T I C L E
Abstract Background Sacral nerve simulation (SNS) is
an accepted therapy for patients with urinary or bowel
dysfunction. However, infection rates are as high as 20%
and can result in removal of the expensive device. We pre-
sent a new video-assisted technique minimizing the risk of
infection. Methods Between April and July 2005, six con-
secutive women of median age 68 years (range, 60–74),
with faecal incontinence (4 patients) and idiopathic con-
stipation (2 patients) underwent video-assisted electrode
implantation for SNS. The motor response of the pelvic
floor during percutaneous nerve evaluation and implanta-
tion of the permanent lead was monitored by a video optic
(same as that normally used for laparoscopic or endoscop-
ic procedures) placed between the legs of the patients. The
video optic and the perianal area were completely covered
with drapes, separating them from the operating field.
Tech Coloproctol (2006) 10:121–124
DOI 10.1007/s10151-006-0264-3
od (unpublished data), the stimulator had to be removed in
one case (2.8%), similar to the 4% removal rate in another
report [12].
This report demonstrates a new video-assisted tech-
nique to avoid infection.
Patients and methods
From April to July 2005, SNS was tested in 6 women with a
median age of 68 years (range, 60–74); 4 patients had faecal
incontinence while 2 had idiopathic constipation. The study was
conducted in accordance with the Declaration of Helsinki. After
patients gave written informed consent to participate the study,
the two-stage procedures were performed in an outpatient set-
ting (<12 hours). All patients received a single dose of antibi-
otics preoperatively (1000 mg cefazolin and 500 mg metronida-
zole intravenously).
Surgical technique
For percutaneous nerve evaluation and implantation of the per-
manent electrode (model 3889, Medtronic, Minneapolis, USA),
patients were prone positioned with slightly bended hips and
knees (Fig. 1). Patient’s feet have to be free in order to observe the
flexion of the great toe as response to stimulation of the third
sacral root. Lateral fluoroscopy of the sacrum is essential for
introducing and correctly placing the tined lead. Additionally, we
placed a video optic (A9394A, 0 degree optic, light cable
WAO03210A and a support A00180A, Olympus, Zurich
Switzerland) between the legs in order to visualize the contraction
of the pelvic floor. The monitor was placed at the patients’ feet.
After disinfection of the sacral area (cranially up to the iliac
crest, laterally 15–20 cm from the anal cleft on each side and cau-
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dally to the tip of the coccyx), a sterile rectangular coverage was
placed. The fluoroscope, the video optic, and the perianal area
were completely covered. The instrumental nurse stood on the
left side of the patient’s leg, and the right-handed surgeon stood
on the right side.
After local anaesthesia, the sacral S3 foramina on both sides
were evaluated for stimulation by introducing the foramen needle
and test electrode. Additionally to the patient’s sensations, the
pelvic contraction was observed on the monitor. The tined lead
was then implanted on the side were the lowest motoric thresh-
old resulted and no disturbing sensation was reported by the
awake patient. Finally, the proximal part of the tined lead elec-
trode was tunnelled to the upper part of the contralateral buttock,
and connected to the percutaneous extension wire (model
3550–05, Medtronic). This extension wire was again tunnelled to
the contralateral buttock, where the wire was exteriorised and the
screening cable (model 3550–03, Medtronic) was connected to
the external pulse generator (model 3625, Medtronic). Permanent
implantation took place immediately after the screening period if
a reduction of symptoms of more than 50% was reported.
Results
We used video imaging to support percutaneous nerve eval-
uation and electrode implantation for sacral nerve stimula-
tion, in 6 women with bowel disfunction. No intraoperative
technical problem occurred. The median duration of screen-
ing period was 15 days (range, 7–22). During this period,
we had no infection and no dislocation of the electrodes. All
but one screening procedures were successful, and a perma-
nent neurostimulator was implanted in five patients. Again,
no complications, especially no wound infection at the lead
or at the pocket of the stimulator in the gluteal area, were
noted mean postoperative follow-up of 8 weeks.
Discussion
The minimally invasive video-assisted percutaneous nerve
evaluation and the placement of the percutaneous tined
lead were performed without any complications.
The use a camera to control the motor responses of the
pelvic floor allows the potentially infected perianal area to
be covered without narrowing the observer’s view.
Furthermore, with the use of an adequate optic and illumi-
nation, even small contractions of the pelvic floor are mag-
nified (magnification, 3 to 4 times in our setting, depend-
ing on the optic and monitor) and better visualised than by
simple eye observation. For surgeons, normally standing at
the side of the patient’s chest, it is more comfortable to
watch the pelvic contraction on the monitor than the lean
forward to look at the perianal area.
It is evident that operations in the perianal area have a
high risk of infection, especially when artificial materials
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Fig. 1 Patient in prone position with slightly bended hips and
knees. Feet have to be free to permit clinicians to observe flexion
of the great toe. Lateral fluoroscopy of the sacrum is essential for
introducing and correctly placing the tined lead. A video optic is
placed between the legs to visualize the contraction of the pelvic
floor. The corresponding monitor is placed at the feet of the patient
are implanted. A lead infection close to the sacral roots is
potentially a life-treating complication and therefore needs
immediate surgical removal of the electrode, debridement
of the wounds and treatment with antibiotics. All preven-
tive measures to avoid direct contact to the perianal region
should be undertaken. Therefore, some centres cover the
perianal area with a transparent foil during the percuta-
neous nerve evaluation and the implantation of an elec-
trode. These special foils are excellent barriers to bacteria
or contaminated material. However, it is very difficult to
attach these foils sufficiently around the anus.
Additionally, steam often reduces the view through the
transparent foil during the procedure. With the use of a
camera, the area of consideration can be easily visualized
and safely covered to avoid any contact with the perianal
region. The two regions (anus and implantation site) are
completely separated and contamination is very unlikely.
The cover sheet is stacked at the level of the tip of the coc-
cyx as shown in Fig. 2. The costs of the described camera
are moderate as most clinics have endoscopic or laparo-
scopic equipment and therefore already have the adequate
camera and monitor. Furthermore, the camera, the light
cable and the support do not need to be sterilised or
draped, which does not increase cost.
Our experience with no infection in six patients is
promising. However, due to the small number of patients
no statistically significant reduction in infection rate could
be seen compared to the period before the use of video,
where we had 4 infections in 40 procedures (10%; unpub-
lished data). Nevertheless, the use of the video during SNS
is simple and does not increase costs, and the theoretical
benefit is overwhelming. Thus, we have implemented the
video-assisted technique as standard practice in our clinic.
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Invited comment
The work of Hetzer and colleagues concerns the “high”
risk of sepsis (20%) in patients submitted to sacral neu-
romodulation, suggesting that the use of videoscopy dur-
ing installation is able to reduce the rate of sepsis. The
authors report that the rate of sepsis during the procedure
can reach up to 20% of patients. Nevertheless such a high
rate was reported only once by Rosen et al. [1] and this
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Fig. 2 After disinfections of the sacral area (cranially up to the iliac
crest, laterally 15–20 cm from the anal verge on each side and cau-
dally to the tip of the coccyx), sterile rectangular coverage is
placed. The fluoroscope and the video optic, as well as the perianal
area, are completely covered. The instrumental nurse will be on the
left side of the patient’s leg; the right-handed surgeon stays on the
right side at the patient’s thorax
not was confirmed by other series that reported infection
rates of 2%–5% [2, 3].
In my opinion, the results of Rosen et al. [1] should not
be considered. Indeed, this series included a large number
of patients with spinal injuries who were, therefore, poten-
tially not responsive. This is the only work that empha-
sized a statistically significant increase of basal and
squeezing pressures. Moreover, explantation occurred in 3
of 20 patients, 0 to 3 months after the procedure, while
Hetzer and colleagues reported that the follow-up of the 6
patients was only 2 months. This cannot exclude that sep-
sis could occur later.
Hetzer and colleagues reported that during a 4-year
experience before implementing videoscopy, only 1
explantation was necessary in a total of 36 procedures
(2.7% and not 3.4%). These data agree with those report-
ed in the literature. However, this is not the 20% rate of
infection that the authors stated in their introduction. In
this paper, a total of 40 procedure with an infection rate
of 10% (4 cases) was reported. How were these four
cases treated? How many of these patients underwent
explantation? 
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In conclusion, in my opinion, videoscopy is a nice idea,
but the small number of patients in this study, the short fol-
low-up and the lack of statistical conclusions do not fully
validate the use of this technique.
V. Ripetti
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Campus Biomedico
Rome, Italy
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